NOT FOR RELEASE, PUBLICATION OR
DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY
JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE
RELEVANT LAWS OF SUCH JURISDICTION.
THIS ANNOUNCEMENT IS FOR INFORMATION
PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY
JURISDICTION.
Publication of Circular and Notice
of Extraordinary General Meeting
24 May 2024
On 16 May 2024, Integrated
Diagnostics Holdings plc ("IDH" or the "Company") announced that it was
proposing to delist its shares from the Egyptian Exchange
("EGX"), whilst maintaining
its existing standard listing on the London Stock
Exchange.
Further to that announcement, the
Company announces that it now intends to proceed with the proposed
delisting of its shares from the EGX and has today published a
circular containing further details of the proposed delisting, the
necessary shareholder resolutions to be considered and, if thought
fit, approved at an Extraordinary General Meeting ("EGM") to be convened and the Notice of
EGM (the "Circular").
The EGM will be held on Wednesday,
12 June 2024 at 1.00 pm (British Summer Time ("BST")) / 3.00 pm local time (Eastern
European Summer Time ("EEST")) at the Headquarters of
Integrated Diagnostics Holdings plc, Building B216-F7, Smart
Village, Giza, Egypt.
If you are unable to attend the EGM
but would like to vote on the resolutions, kindly request to submit
your proxy vote online at https://www.signalshares.com/
or via CREST in accordance with the instructions
set out in note 2 of the Explanatory Notes to the Notice of EGM.
Shareholders are strongly encouraged to submit their proxy votes
online at https://www.signalshares.com/ or
via CREST where applicable. Proxy votes must be received
by 1.00 pm (BST) / 3.00 pm local time (EEST) on Monday,
10 June 2024.
The Board of Directors of the
Company (the "Board")
remains keen to encourage engagement with shareholders. To that
end, the Board would like to invite questions from shareholders in
advance of and during the EGM. Should shareholders wish to submit
questions to the Board prior to the deadline for proxy voting they
can do so, and these will be responded to on an individual basis.
In addition, the Board will offer shareholders the opportunity to
dial into the EGM, at which time they can also submit questions to
the Board.
Shareholders wishing to access the
dial-in facility or submit questions are asked to email Tarek
Yehia at tarek.yehia@idh.com
by close of business on Wednesday, 5
June 2024.
A copy of the Circular will shortly
be available on the Company's
website: https://www.idhcorp.com/
and for inspection at the National Storage
Mechanism: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
For further information please
contact:
Integrated Diagnostics Holdings plc
Tarek Yehia
Investor Relations
Director
T: +20 (0)2 3332 1126 | M: +20 10
6882 6678 | tarek.yehia@idhcorp.com
Company Secretary
Company Matters
IDHLondon@linkgroup.co.uk
-Ends-
Important disclaimers (including in relation to securities law
restrictions)
This announcement is for information
purposes only and is not intended to and does not constitute or
form part of an investment recommendation or any offer to buy or
sell or subscribe for or any invitation to buy, sell or subscribe
for any securities in any jurisdiction. Any decision or response in
relation to the proposed delisting of the Company's shares from the
EGX should made solely on the basis of the information contained in
the Circular.
This announcement may contain
certain forward-looking statements. A forward-looking statement is
any statement that does not relate to historical facts and events,
and can be identified by the use of such words and phrases as
"according to estimates", "aims", "anticipates", "assumes",
"believes", "could", "estimates", "expects", "forecasts",
"intends", "is of the opinion", "may", "plans", "potential",
"predicts", "projects", "should", "to the knowledge of", "will",
"would" or, in each case their negatives or other similar
expressions, which are intended to identify a statement as
forward-looking. This applies, in particular, to statements
containing information on future financial results, plans, or
expectations regarding business and management, future growth or
profitability and general economic and regulatory conditions and
other matters affecting the Company and its subsidiaries (the
"Group").
Forward-looking statements reflect
the current views of the Group's management ("Management") on future events, which
are based on the assumptions of the Management and involve known
and unknown risks, uncertainties and other factors that may cause
the Group's actual results, performance or achievements to be
materially different from any future results, performance or
achievements expressed or implied by these forward-looking
statements. The occurrence or non-occurrence of an assumption could
cause the Group's actual financial condition and results of
operations to differ materially from, or fail to meet expectations
expressed or implied by, such forward-looking
statements.
The Group's business is subject to a
number of risks and uncertainties that could also cause a
forward-looking statement, estimate or prediction to differ
materially from those expressed or implied by the forward-looking
statements contained in this announcement. The information,
opinions and forward-looking statements contained in this
announcement speak only as at its date and are subject to change
without notice. Save as required by applicable law, the Group does
not undertake any obligation to review, update, confirm or to
release publicly any revisions to any forward-looking statements to
reflect events that occur or circumstances that arise in relation
to the content of this announcement.